Oncolytics Biotech (ONCY) Tops Q1 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Cognyte Software (CGNT) Tops Q2 EPS by 4c
• J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance